Home / business / Gilead Sciences Raises 2020 Sales Outlook to Include Covid-19 Treatment Remdesivir

Gilead Sciences Raises 2020 Sales Outlook to Include Covid-19 Treatment Remdesivir

-
Gilead said it expects total 2020 sales of $23 billion to $25 billion, up from its previous range of $21.8 billion to $22.2 billion.

from Top Business News- News18.com
Read The Rest:timesnownews...
Gilead Sciences Raises 2020 Sales Outlook to Include Covid-19 Treatment Remdesivir Gilead Sciences Raises 2020 Sales Outlook to Include Covid-19 Treatment Remdesivir Reviewed by Team Exprssnews on July 30, 2020 Rating: 5

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.